There was no difference in either TNIP1 or GPX3 expression between ALS cases and controls (p = 0.36 and 0.12, respectively), and the lead risk SNP did not identify an association with expression (Additional file 2: Fig. S8A-D). The gene discussed is GPX3; the disease is amyotrophic lateral sclerosis.